Insider Trading & Ownership - Papapetropoulos Spyros

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Papapetropoulos Spyros
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-11-22
Purchase
2022-11-28
4:33 pm
Lipocine Inc.LPCNPapapetropoulos Spyros
Director
21,739$0.47$10,21721,739
(Direct)
View
2022-11-18
Sale
2022-11-22
9:45 pm
Vigil Neuroscience Inc.VIGLPapapetropoulos Spyros
Chief Medical Officer
300$14$4,200153,604
(Direct)
View
2022-05-03
Purchase
2022-05-04
07:00 am
Vigil Neuroscience Inc.VIGLPapapetropoulos Spyros
Chief Medical Officer
4,000$3.3978$13,5914,000
(Direct)
View
2021-03-11
Purchase
2021-03-15
3:24 pm
Adamas Pharmaceuticals IncADMSPapapetropoulos Spyridon
Director
5,975$5.06$30,23315,975
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-05-10
Option Award
2023-05-12
4:37 pm
2024-05-10
2033-05-10
Lipocine Inc.LPCNPapapetropoulos Spyros
Director
30,000$0.265662,000
(Direct)
View
2022-11-18
Exercise
2022-11-22
9:45 pm
N/A
2030-11-18
Vigil Neuroscience Inc.VIGLPapapetropoulos Spyros
Chief Medical Officer
300$0153,604
(Direct)
View
2022-11-18
Exercise
2022-11-22
9:45 pm
N/A
N/A
Vigil Neuroscience Inc.VIGLPapapetropoulos Spyros
Chief Medical Officer
300$1.89153,604
(Direct)
View
2022-06-08
Option Award
2022-06-10
11:34 am
2023-06-08
2032-06-08
Lipocine Inc.LPCNPapapetropoulos Spyros
Director
22,000$0.9232,000
(Direct)
View
2022-04-11
Option Award
2022-04-12
5:00 pm
2023-04-11
2032-04-11
Lipocine Inc.LPCNPapapetropoulos Spyros
Director
10,000$1.1610,000
(Direct)
View
2022-03-01
Option Award
2022-03-03
4:05 pm
N/A
2032-03-01
Vigil Neuroscience Inc.VIGLPapapetropoulos Spyridon
Chief Medical Officer
75,500$075,500
(Direct)
View

Ownership
2022-01-06
8:31 pm
N/A
2030-11-18
Vigil Neuroscience Inc.VIGLPapapetropoulos Spyridon
Chief Medical Officer
0$0293,004
(Direct)
View
2021-11-24
Disposition
2021-11-24
4:09 pm
N/A
2030-11-21
Adamas Pharmaceuticals IncADMSPapapetropoulos Spyridon
Director
30,000$00
(Direct)
View
2021-11-24
Equity Swap
2021-11-24
4:09 pm
N/A
N/A
Adamas Pharmaceuticals IncADMSPapapetropoulos Spyridon
Director
20,975$00
(Direct)
View
2021-06-02
Option Award
2021-06-04
4:16 pm
2022-06-02
2031-06-01
Adamas Pharmaceuticals IncADMSPapapetropoulos Spyridon
Director
15,000$030,975
(Direct)
View
2020-11-22
Option Award
2020-11-24
5:57 pm
N/A
2030-11-21
Adamas Pharmaceuticals IncADMSPapapetropoulos Spyridon
Director
30,000$030,000
(Direct)
View

Ownership
2020-11-24
5:52 pm
N/A
N/A
Adamas Pharmaceuticals IncADMSPapapetropoulos Spyridon
Director
0$00
(Direct)
View